The Global Enzyme Replacement Therapy Market accounted for US$ 8.24 billion in 2020 and is estimated to be US$ 16.94 billion by 2030 and is anticipated to register a CAGR of 7.50%. Enzyme replacement therapy (ERT) is a clinical treatment which replaces a chemical that is lacking or missing in the body. Typically, this is finished by giving the patient an intravenous (IV) mixture of an answer containing the protein. ERT is as of now accessible for some lysosomal stockpiling infections: Gaucher sickness, Fabry illness, MPS I, MPS II (Hunter disorder), MPS VI and Pompe illness. ERT doesn't right the fundamental hereditary imperfection, yet it builds the grouping of the protein that the patient is lacking. ERT has likewise been utilized to treat patients with extreme joined immunodeficiency (SCID) coming about because of an adenosine deaminase insufficiency (ADA-SCID). Other treatment alternatives for patients with chemical or protein lacks incorporate substrate decrease treatment, quality treatment, and bone-marrow determined foundational microorganism transplantation.

The report “Global Enzyme Replacement Therapy Market, By Enzyme Type (Agalsidase Beta, Velaglucerase Alfa, Imiglucerase, Taliglucerase, Alglucosidase, Alfa, Laronidase, Idursulfase, Galsulfase, Pegademase, and Others), By Indication (Fabry Disease, Gaucher Disease, Pompe Disease, Scheie Syndrome, Hunter Disease, Maroteaux-Lamy Syndrome, and Others), By End User ( Hospitals, Clinics, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030”

Key Highlights:

In 2021, The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Sanofi SA's SNY avalglucosidase alfa for Pompe disease.
In 2019, Global biopharmaceutical company Takeda announced the launch of the enzyme replacement therapy for 'lysosomal storage disorders' (LSDs), in an attempt to expand its portfolio of rare disease therapies in India.
Analyst View:

Rising awareness and an expanding number of market players wandering into vagrant sickness the board are key components impelling the market development. Vagrant medications that are utilized to treat these infections are expected to thrive during the estimate time frame attributable to the rising number of players putting resources into R&D to treat these uncommon sicknesses.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Enzyme Replacement Therapy Market, By Enzyme Type (Agalsidase Beta, Velaglucerase Alfa, Imiglucerase, Taliglucerase, Alglucosidase, Alfa, Laronidase, Idursulfase, Galsulfase, Pegademase, and Others), By Indication (Fabry Disease, Gaucher Disease, Pompe Disease, Scheie Syndrome, Hunter Disease, Maroteaux-Lamy Syndrome, and Others), By End User ( Hospitals, Clinics, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Enzyme-Replacement-Therapy-Market-34

Key Market Insights from the report:

The Global Enzyme Replacement Therapy Market accounted for US$ 8.24 billion in 2020 and is estimated to be US$ 16.94 billion by 2030 and is anticipated to register a CAGR of 7.50%. The Global Enzyme Replacement Therapy Market has been segmented on the basis of enzyme type, indication, end-user, and region.

By Enzyme Type, the Global Enzyme Replacement Therapy Market is segmented into Agalsidase Beta, Velaglucerase Alfa, Imiglucerase, Taliglucerase, Alglucosidase Alfa, Laronidase, Idursulfase, Galsulfase, Pegademase, and Others.
By Indication, the Global Enzyme Replacement Therapy Market is segmented into Fabry Disease, Gaucher Disease, Pompe Disease, Scheie Syndrome, Hunter Disease, Maroteaux-Lamy Syndrome, and Others.
By End-User, the Global Enzyme Replacement Therapy Market is segmented into Hospitals, Clinics and Home care setting.
By region, the Global Enzyme Replacement Therapy Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape:

Key players operating in the global market of enzyme replacement therapy include Shire plc, Amicus Therapeutics, Genzyme Corporation, Pfizer Inc., BioMarin Pharmaceutical, Inc., Sigma-Tau Pharmaceuticals, Inc., Essential Pharmaceuticals Limited, Merck KGa, and AbbVie Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
Key Topics Covered

Introduction
Study Deliverables
Study Assumptions
Scope of the Study
Research Methodology
Executive Summary
Opportunity Map Analysis
Market at Glance
Market Share (%) and BPS Analysis, by Region
Competitive Landscape
Heat Map Analysis
Market Presence and Specificity Analysis
Investment Analysis
Competitive Analysis
To know more

Contact Us:

Sales

Prophecy Market Insights

1 860 531 2701

Email- [email protected]